Newleos Therapeutics, Inc.

Funding and NIH signals

• NIH award NIH awarded $3.1M (NIH grant 1UG3DA066264-01, new, notice Sep 8, 2026). NIH RePORTER 1UG3DA066264-01 (Sep 8, 2026)
  Evidence (1 event)

  • Sep 8, 2026 · NIH RePORTER 1UG3DA066264-01
    Organization: NEWLEOS THERAPEUTICS, INC.; City/State: HOPKINTON, MA; Project number: 1UG3DA066264-01; Activity code: UG3; Fiscal year: 2026; Award notice date: 2026-09-08; FY total cost (award amount): 3097247; Administering IC: National Institute on Drug Abuse; Project title: NTX-2001, a trace amine-associated receptor 1 (TAAR1) partial agonist, for the treatment of Cocaine Use Disorder; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals